Health
2021 Japan Prize Laureates Announced
TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced onJanuary 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy...
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company
SUZHOU, China and ROCKVILLE, Md., Jan. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...
12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC
NYON, Switzerland, Jan. 29, 2021 /PRNewswire/ -- 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAllianc...
Alfasigma to expand its digital footprint
Online doctorAsyou, a web platform entirely dedicated to physicians The website optimizes research on the most important and autoritative medical databases such as Pubmed, ICTRP and ClinicalTrials.gov. An entirely new area presents online courses for physicians on several different topics BOLO...
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals
TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
"Right to Work" Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy to Be Launched with Endorsement of International Trade Union Confederation
TOKYO and BRUSSELS, Jan. 28, 2021 /PRNewswire/ -- The 16th Global Appeal to End
Stigma and Discrimination against Persons Affected by Leprosy will be launched
in an online ceremony onJanuary 31, 2021, World Leprosy Day.
Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA
SEOUL, South Korea, Jan. 28, 2021 /PRNewswire/ -- Immunoforge, the company specializing in the development of new drugs for rare musculoskeletal diseases (Representatives: An Seong-Min and Jang Gi-Ho), announced that their new drug candidate PF1801 has been designated as the FDA orphan drug for t...
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged
VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. T...
Zeus Launches Reinforced Polyimide Tubing
Expanded Capabilities Help Customers Consolidate Suppliers, Innovate, and Go to Market With Confidence ORANGEBURG, S.C., Jan. 28, 2021 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, announced today that it has added bra...
Technology Innovations and Virtual Consultations Drive the Healthcare Industry Transformation by 2025
SANTA CLARA, Calif., Jan. 28, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Vision 2025—Rising Healthcare Expenditures and Disproportionate Improvement in Patient Outcomes Spur Disruptive Changes in the Global Healthcare Industry, forecasts that global healthcare revenues in 2025 will ...
IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Advancing diversity in veterinary medicine through nine full scholarships and integrated support WESTBROOK, Maine, Jan. 28, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today a landmark initiative with theTuskegee...
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil
SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the clinical trial (the "Trial") of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board ("IRB") ofBrazil. The trial was accept...
CROMSOURCE Consolidates Strategic Site Support Service
VERONA, Italy, Jan. 28, 2021 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), announced today the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies...
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK
MANCHESTER, England and HYDERABAD, India, Jan. 28, 2021 /PRNewswire/ -- Sai
Life Sciences, one ofIndia's fastest growing Contract Research, Development &
Manufacturing Organizations
Envirotainer Opens 3rd Indian Station in Bangalore
UPPLANDS VÄSBY, Sweden, Jan. 28, 2021 /PRNewswire/ -- Envirotainer, the global market leader and by far the largest provider of secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their global station network by adding a third station inIndia,...
SC Johnson Partners With Habitat for Humanity to Provide Access to Housing, Clean Water and Sanitation across Asia Pacific
RACINE, Wis., Jan. 28, 2021 /PRNewswire/ -- In response to the unprecedented impact of the COVID-19 pandemic on underserved communities, SC Johnson is teaming with Habitat for Humanity to provide access to housing and proper water, sanitation and hygiene (WASH) facilities for hundreds of families...
Tencent Cloud raises the bar of crowd management through intelligent cloud solutions and AI technology suitable for all organizations
BANGKOK, Jan. 28, 2021 /PRNewswire/ -- Tencent Cloud, the cloud business of Tencent, today introduces its intelligent cloud solutions and artificial intelligence (AI) technology that could be leveraged for crowd management in the Southeast Asia amid the pandemic. The company offers a suite of solu...
Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142.HK), announced today that China Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab (HBM 9161), a fully human anti-FcRn monoclonal a...
Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering
RARITAN, N.J., Jan. 28, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its i...
Women's reproductive healthcare in Asia gets boost with first at-home blood-testing kit for female fertility
BANGKOK, Jan. 28, 2021 /PRNewswire/ -- Health start-up Yesmom announced today
its launch ofAsia's first at-home blood testing kits for female fertility,
designed to help women stay on the front foot of their reproductive health from
the comfort of home.
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 292 media titles]
2024-11-13 09:00Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11